BELFB vs BRZE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BELFB exhibits weak fundamental health with a Piotroski F-Score of 3/9, indicating significant financial fragility. Despite strong recent earnings and revenue growth—YoY earnings up 172.9% and revenue up 44.8%—the stock trades at a premium valuation (P/E 40.52 vs. sector avg 93.05) with limited margin of safety relative to the Graham Number of $60.72. Robust profitability metrics like 17.09% operating margin and 16.91% ROE are offset by bearish insider activity and deteriorating technical trends (10/100). While analyst consensus is strong_buy, conflicting signals across valuation, health, and insider behavior warrant caution.
BRZE shows neutral fundamentals based on deterministic rules. Financial strength is stable (F-Score 5/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
BELFB vs BRZE: Head-to-Head Comparison
This page compares Bel Fuse Inc. (BELFB) and Braze, Inc. (BRZE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.